Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin in Pediatric Community-Acquired Pneumonia
NCT00034736Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Aug 2002
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of levofloxacin in community acquired pneumonia (CAP), sponsored by Johnson & Johnson. Started Aug 2002; status: completed.
02
Drugs
levofloxacin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT00034736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00034736.